Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
15
AKYA Quote, Financials, Valuation and Earnings
Last price:
$1.63
Seasonality move
:
-32.17%
Day range:
$1.39 - $1.62
52-week range:
$1.39 - $5.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.98x
P/B ratio:
10.57x
Volume:
470.7K
Avg. volume:
381.2K
1-year change:
-67.21%
Market cap:
$80.3M
Revenue:
$81.7M
EPS (TTM):
-$1.13
AKYA Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Akoya Biosciences shares anticipate an average target of $3.48, ranging from a low estimate of $2.40 to a high estimate of $5.00. This average target implies a growth of 114.51% compared to the current stock price of $1.62.
Consensus Price Target
$3.48
Highest Price Target
$5.00
Lowest Price Target
$2.40
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 0 | 0 |
| Hold | 4 | 0 | 7 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | -- | Hold |
AKYA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 9.57% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is down 0.13% over the past day.
